GVK BIO entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), to discover drug candidates focused on pre-defined discovery targets. GVK BIO will utilize in-house capabilities in Discovery Chemistry, Informatics, Biology and ADME to advance this program. GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds towards clinical studies. Under the agreement, GVK BIO will receive an initial payment and will be eligible for success-based milestone payments.

Inogent Laboratories (Inogent Labs), a Hyderabad-based custom synthesis and API manufacturing company, announced the appointment of Rajiv Varma as the new President of the company. In his new role as President, Varma will be responsible for Inogent operations and help the company grow as a leading contract research and custom manufacturing services provider.

GVK Biosciences will launch a manually curated database of clinical biomarkers that it has been developing in collaboration with an undisclosed large pharmaceutical firm for two years. It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.

GVK BIO, a leading Pharma & Biotech research and development outsourcing company, announced that Sequoia Capital a leading global private investment firm has invested Rs.100 crores in the company.
It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.

The GVK BIO-Wyeth Hyderabad Chemistry Center was inaugurated by Dr. Robert Ruffolo, President R&D, Wyeth Pharma. Mr. David Hopper, the Consul General, United States Consulate, Chennai

GVK Biosciences and Wyeth Pharma organized an international symposium on the 05th of October 2007 on “New Dimensions in Organic Synthesis” at the Hyderabad International Convention Center (HICC). World renowned leaders in Chemistry presented on various topics including crystal engineering, chemical tools for the study of complex biological systems, approaches to novel chemical reactions, synergy between natural products & drug discovery and total synthesis efforts.

GVK Biosciences Pvt. Ltd. is one of India’s premier CROs with a leadership position in Drug Discovery services. It has shown consistent growth by strengthening its leadership in core areas (Medicinal Chemistry, Informatics) and expanding into new service offerings (spanning Drug Discovery to Development and Custom Synthesis). It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.

GVK BIO will be at the following conferences this year. Please contact us if you are interested to meet us at any of the conferences.